These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29443333)

  • 21. Potential problems and solutions with inhaler use in elderly COPD patients.
    Nobles J; Hutchison AM
    Consult Pharm; 2014 Nov; 29(11):753-6. PubMed ID: 25369190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaler devices for patients with COPD.
    Fink JB; Colice GL; Hodder R
    COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhaled in chronic obstructive pulmonary disease therapy update].
    Viejo-Casas A; Bonnardeaux-Chadburn C; Ginel-Mendoza L; Quintano-Jimenez JA
    Semergen; 2016 Oct; 42(7):e101-e107. PubMed ID: 26653338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
    Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
    Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.
    Capstick TG; Clifton IJ
    Expert Rev Respir Med; 2012 Feb; 6(1):91-101; quiz 102-3. PubMed ID: 22283582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Customizing inhaled therapy to meet the needs of COPD patients.
    Fromer L; Goodwin E; Walsh J
    Postgrad Med; 2010 Mar; 122(2):83-93. PubMed ID: 20203459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COPD inhaler therapy: A path to success.
    Arnold M; Vordtriede C; Chadwick C; Trivette E
    J Fam Pract; 2022 Sep; 71(7):280-289. PubMed ID: 36179143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus.
    Miravitlles M; Soler-Cataluña JJ; Alcázar B; Viejo JL; García-Río F
    Pulm Pharmacol Ther; 2018 Feb; 48():97-103. PubMed ID: 29031616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S; McGovern V; Roberts J; Scullion JE; Singh D
    Int J Chron Obstruct Pulmon Dis; 2019; 14():391-401. PubMed ID: 30863039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaler devices in asthma and COPD--an assessment of inhaler technique and patient preferences.
    Chorão P; Pereira AM; Fonseca JA
    Respir Med; 2014 Jul; 108(7):968-75. PubMed ID: 24873873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations for Geriatric Patients with COPD.
    Neumann N; Odegard P; Swanoski M
    Consult Pharm; 2018 Apr; 33(4):210-214. PubMed ID: 29609699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.
    Miravitlles M; Montero-Caballero J; Richard F; Santos S; Garcia-Rivero JL; Ortega F; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2016; 11():407-15. PubMed ID: 27013871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis.
    Navaie M; Dembek C; Cho-Reyes S; Yeh K; Celli BR
    Medicine (Baltimore); 2020 Jun; 99(25):e20718. PubMed ID: 32569208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch.
    Hanada S; Wada S; Ohno T; Sawaguchi H; Muraki M; Tohda Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():69-77. PubMed ID: 25609941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rating criteria for selection of an inhaler and instructing its use in patients with asthma and COPD].
    Ludwikowski R; Płusa T; Bijoś P
    Pol Merkur Lekarski; 2016 Dec; 41(246):279-282. PubMed ID: 28024131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient perceptions of the re-usable Respimatt
    Dreher M; Price D; Gardev A; Peeters P; Arora S; van der Sar-van der Brugge S; Dekhuijzen R; Usmani OS
    Chron Respir Dis; 2021; 18():1479973120986228. PubMed ID: 33522304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintaining Control of Chronic Obstructive Airway Disease: Adherence to Inhaled Therapy and Risks and Benefits of Switching Devices.
    Melani AS; Paleari D
    COPD; 2016; 13(2):241-50. PubMed ID: 26407924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.